Know Cancer

or
forgot password
  • cancer clinical trials in dodge city, KS

  • Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    Cancer Center of Kansas - Dodge City
    Dodge City, Kansas 67801
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
    Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32
    Cancer Center of Kansas, PA - Dodge City
    Dodge City, Kansas 67801
    Breast Cancer, Depression, Fatigue, Sleep Disorders
    S1014 Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone Therapy
    Cancer Center of Kansas, PA - Dodge City
    Dodge City, Kansas 67801
    Prostate Cancer
    S0820, Adenoma and Second Primary Prevention Trial
    Cancer Center of Kansas - Dodge City
    Dodge City, Kansas 67801
    Colorectal Neoplasms
    PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma
    Cancer Center of Kansas, PA - Dodge City
    Dodge City, Kansas 67801
    Lymphoma
    Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer
    Cancer Center of Kansas, PA - Dodge City
    Dodge City, Kansas 67801
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Peritoneal Cancer
    Cancer Center of Kansas, PA - Dodge City
    Dodge City, Kansas 67801
    Anxiety Disorder, Fallopian Tube Cancer, Fatigue, Nausea and Vomiting, Neurotoxicity, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
    Cancer Center of Kansas, PA - Dodge City
    Dodge City, Kansas 67801
    Cancer
    S1013: Validation of Cancer Questionnaire for Skin Toxicities in Patients With Colorectal Cancer or Lung Cancer Receiving Cetuximab, Panitumumab, or Erlotinib Hydrochloride
    Cancer Center of Kansas, PA - Dodge City
    Dodge City, Kansas 67801
    Colorectal Cancer, Dermatologic Complications, Lung Cancer, Therapy-related Toxicity
    Magnesium Oxide in Treating Postmenopausal Women With Hot Flashes and a History of Breast Cancer
    Cancer Center of Kansas, PA - Dodge City
    Dodge City, Kansas 67801
    Breast Cancer, Cancer Survivor, Hot Flashes
    Alisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma
    Cancer Center of Kansas - Dodge City
    Dodge City, Kansas 67801
    Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Hepatosplenic T-cell Lymphoma, Peripheral T-cell Lymphoma, Recurrent Adult Non-Hodgkin Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma
    Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Persistent or Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer
    Cancer Center of Kansas - Dodge City
    Dodge City, Kansas 67801
    Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer
    S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer
    Cancer Center of Kansas, PA - Dodge City
    Dodge City, Kansas 67801
    Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer, Gastric Cancer
    S1105: Text-Messaging Intervention to Reduce Early Discontinuation of AI Therapy in Women With Early-Stage Breast Cancer
    Cancer Center of Kansas, PA - Dodge City
    Dodge City, Kansas 67801
    Breast Cancer
    Veliparib in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
    Cancer Center of Kansas - Dodge City
    Dodge City, Kansas 67801
    BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer
    Studying the Physical Function and Quality of Life Before and After Surgery in Patients With Stage I Cervical Cancer
    Cancer Center of Kansas - Dodge City
    Dodge City, Kansas 67801
    Cervical Cancer, Lymphedema, Sexuality and Reproductive Issues
    Alisertib in Treating Patients With Advanced or Metastatic Sarcoma
    Cancer Center of Kansas - Dodge City
    Dodge City, Kansas 67801
    Adult Alveolar Soft-part Sarcoma, Adult Angiosarcoma, Adult Epithelioid Sarcoma, Adult Extraskeletal Chondrosarcoma, Adult Fibrosarcoma, Adult Leiomyosarcoma, Adult Liposarcoma, Adult Neurofibrosarcoma, Chondrosarcoma, Endometrial Stromal Sarcoma, Mast Cell Sarcoma, Metastatic Adult Malignant Fibrous Histiocytoma of Bone, Ovarian Carcinosarcoma, Ovarian Sarcoma, Recurrent Adult Malignant Fibrous Histiocytoma of Bone, Recurrent Adult Soft Tissue Sarcoma, Small Intestine Leiomyosarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma
    Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy
    Cancer Center of Kansas - Dodge City
    Dodge City, Kansas 67801
    Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer
    Tivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Kidney Cancer That Cannot be Removed by Surgery
    Cancer Center of Kansas - Dodge City
    Dodge City, Kansas 67801
    Childhood Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer, Type 1 Papillary Renal Cell Carcinoma, Type 2 Papillary Renal Cell Carcinoma
    Ipilimumab With or Without High-Dose Recombinant Interferon Alfa-2b in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed By Surgery
    Cancer Center of Kansas - Dodge City
    Dodge City, Kansas 67801
    Recurrent Melanoma, Stage IIIA Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
    Armodafinil in Reducing Cancer-Related Fatigue in Patients With Glioblastoma Multiforme
    Cancer Center of Kansas - Dodge City
    Dodge City, Kansas 67801
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Fatigue
    Cytarabine and Daunorubicin Hydrochloride or Idarubicin and Cytarabine With or Without Vorinostat in Treating Younger Patients With Previously Untreated Acute Myeloid Leukemia
    Cancer Center of Kansas - Dodge City
    Dodge City, Kansas 67801
    Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia
    SWOG-9430: Surgery in Treating Patients With Metastatic Melanoma
    Cancer Center of Kansas - Dodge City
    Dodge City, Kansas 67801
    Melanoma (Skin)
    Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
    Cancer Center of Kansas - Dodge City

    Trial Locations
    Cancer Center of Kansas - Dodge City
    Radiation Oncology Center
    Colorectal Cancer
    S9912 Combination Chemo in Stage III Ovarian Cancer,
    Cancer Center of Kansas - Dodge City
    Dodge City, Kansas 67801
    Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer
    Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
    Cancer Center of Kansas - Dodge City
    Dodge City, Kansas 67801
    Drug/Agent Toxicity by Tissue/Organ, Lung Cancer, Radiation Toxicity
    Combination Chemotherapy in Treating Patients With Bladder Cancer
    Cancer Center of Kansas - Dodge City
    Dodge City, Kansas 67801
    Bladder Cancer
    S0001 RT and Carmustine With or Without O6BG in Patients With New Glioblastoma Multiforme or Gliosarcoma
    Cancer Center of Kansas - Dodge City
    Dodge City, Kansas 67801
    Malignant Neoplasms of Eye, Brain and Other Parts of Central Nervous System
    S0028, Gemcitabine and Paclitaxel in Treating Patients With Advanced or Recurrent Cancer of the Urinary Tract
    Cancer Center of Kansas, PA - Dodge City
    Dodge City, Kansas 67801
    Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer
    Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
    Cancer Center of Kansas, PA - Dodge City
    Dodge City, Kansas 67801
    Hot Flashes, Prostate Cancer
    S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or Cholangiocarcinoma
    Cancer Center of Kansas - Dodge City
    Dodge City, Kansas 67801
    Extrahepatic Bile Duct Cancer, Gallbladder Cancer
    S0215 Trastuzumab, Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer
    Cancer Center of Kansas, PA - Dodge City
    Dodge City, Kansas 67801
    Breast Cancer
    Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer
    Cancer Center of Kansas - Dodge City
    Dodge City, Kansas 67801
    Osteoporosis, Prostate Cancer
    S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the Urothelium
    Cancer Center of Kansas, PA - Dodge City
    Dodge City, Kansas 67801
    Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer
    EGb761 in Maintaining Mental Clarity in Women Receiving Chemotherapy for Newly Diagnosed Breast Cancer
    Cancer Center of Kansas, PA - Dodge City
    Dodge City, Kansas 67801
    Breast Cancer, Neurotoxicity
    Daunorubicin & Cytarabine +/- Zosuquidar inTreating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory Anemia
    Cancer Center of Kansas - Dodge City
    Dodge City, Kansas 67801
    Leukemia, Myelodysplastic Syndromes
    S0117 Gemtuzumab Ozogamicin Plus Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia
    Cancer Center of Kansas - Dodge City
    Dodge City, Kansas 67801
    Leukemia
    Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer
    Cancer Center of Kansas - Dodge City
    Dodge City, Kansas 67801
    Pancreatic Cancer
    Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the Urothelium
    Cancer Center of Kansas - Dodge City
    Dodge City, Kansas 67801
    Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer
    Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
    Cancer Center of Kansas, P.A. - Dodge City
    Dodge City, Kansas 67801
    Breast Cancer, Osteoporosis
    Docetaxel and Capecitabine in Treating Patients With Metastatic Cancer of the Stomach or Gastroesophageal Junction
    Cancer Center of Kansas, PA - Dodge City
    Dodge City, Kansas 67801
    Esophageal Cancer, Gastric Cancer
    Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer
    Cancer Center of Kansas, PA - Dodge City
    Dodge City, Kansas 67801
    Colorectal Cancer, Metastatic Cancer
    Brain Irradiation in Treating Patients With Limited-Stage Small Cell Lung Cancer
    Cancer Center of Kansas, PA - Dodge City
    Dodge City, Kansas 67801
    Lung Cancer
    Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Cancer Center of Kansas, PA - Dodge City
    Dodge City, Kansas 67801
    Extensive Stage Small Cell Lung Cancer
    Lidocaine Patch in Treating Cancer Patients With Neuropathic Pain After Surgery
    Cancer Center of Kansas, PA - Dodge City
    Dodge City, Kansas 67801
    Pain, Unspecified Adult Solid Tumor, Protocol Specific
    Gemcitabine Plus Pemetrexed Disodium in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer
    Cancer Center of Kansas, PA - Dodge City
    Dodge City, Kansas 67801
    Extrahepatic Bile Duct Cancer, Gallbladder Cancer, Liver Cancer
    Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Waldenstrom's Macroglobulinemia
    Cancer Center of Kansas, PA - Dodge City
    Dodge City, Kansas 67801
    Lymphoma
    Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer
    Cancer Center of Kansas, PA - Dodge City
    Dodge City, Kansas 67801
    Anemia, Fatigue, Prostate Cancer
    Sorafenib in Treating Patients With Refractory Non-Small Cell Lung Cancer
    Cancer Center of Kansas, PA - Dodge City
    Dodge City, Kansas 67801
    Lung Cancer
    S0222: Tirapazamine Combined With Chemo and RT in Limited-Stage Small Cell Lung Cancer
    Cancer Center of Kansas, PA - Dodge City
    Dodge City, Kansas 67801
    Lung Cancer
    S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer
    Cancer Center of Kansas, P.A. - Dodge City
    Dodge City, Kansas 67801
    Pancreatic Cancer
    Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
    Cancer Center of Kansas, PA - Dodge City
    Dodge City, Kansas 67801
    Breast Cancer
    Tetracycline in Preventing Skin Rash in Patients Who Are Receiving Drugs Such as Gefitinib and Cetuximab for Cancer
    Cancer Center of Kansas, PA - Dodge City
    Dodge City, Kansas 67801
    Unspecified Adult Solid Tumor, Protocol Specific
    S0415 Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
    Cancer Center of Kansas, PA - Dodge City
    Dodge City, Kansas 67801
    Esophageal Cancer